key: cord-0922068-5srd5pp2
authors: Rosenbaum, J. E.; Castro Ochoa, K.; Hasan, F.; Goldfarb, A.; Tang, V.; Tomer, G.; Wallach, T.
title: Epidemiologic Assessment of Pediatric Inflammatory Bowel Disease Presentation in NYC During COVID-19
date: 2022-03-27
journal: nan
DOI: 10.1101/2022.03.23.22272167
sha: 38be1cd176612197dfac7893ef39959b63cd3c2e
doc_id: 922068
cord_uid: 5srd5pp2

SARS-nCoV2 may have increased capacity to generate autoimmune disease; multiple reports suggest increased risk of Type 1 Diabetes, and case reports suggest other autoimmune linkages. Inflammatory Bowel Disease (IBD) pathogenesis appears to be a mix of genetic susceptibility, microbial populations, and immune triggers such as infections. Given the perceived role of infection in pathogenesis, decreased incidence of all infections during the pandemic secondary to non-pharmaceutical interventions should decrease IBD incidence rates. The aim of this study was to evaluate the association between the Covid-19 pandemic and IBD presentation in NYC using data from new diagnoses at a consortium of institutions. Using EMR systems all diagnoses at 4 collaborating institutions were retrieved from 2015-2021. We fit time series model (ARIMA) to the quarterly number of cases of each disease for January 2016-March 2020 and forecast the subsequent 21 months. We not only did not observe a decline in pediatric IBD secondary to absent viral illness, but noted a statistically significant increase in Crohn's Disease approximately 6 months after the initial 2020 COVID wave in NYC, and trends suggesting increases overall in IBD diagnoses above the existing trend towards increased disease presentation that pre-dated the pandemic. This data suggests that there may be a linkage between SARS-nCoV2 infection rates and subsequent pediatric IBD presentation, warranting further evaluation in the aftermath of the Omicron wave.

The SARS-nCoV2 pandemic has created multiple challenges, but emerging data Given the hypothesized role of infection in pathogenesis, decreased incidence of all 79 infections during the pandemic secondary to non-pharmaceutical interventions (NPI) 80 would likely be expected to generate a decrease in IBD incidence 4, 5 . As the first US locus 81 of a major SARS-nCoV2 outbreak, New York City represents a unique opportunity to 82 identify any signal of altered IBD presentation secondary to infection and the NPI 83 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 27, 2022. ;  implemented to manage the pandemic. This study will evaluate any association between the Covid-19 pandemic and new IBD diagnoses in NYC using data from a consortium of 85 institutions. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 27, 2022. ;  contribute to these EHR systems.

Due to potentially different seasonal variation and time to presentation, we 121 analyzed CD and UC separately and excluded 22 cases of indeterminate IBD.

Using April 2020 as the first month of the covid-19 pandemic, we compared pre- with 80% and 95% prediction intervals using the forecast library. 5 The model for To show seasonal patterns in diagnoses, we plotted total cases by month with loess 143 regression and 95% confidence intervals using ggplot2 stratified by pandemic versus pre- 

Patients diagnosed during the pandemic did not differ in demographic 150 characteristics from patients diagnosed before the pandemic ( Table 1) . Downstate had a 151 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 27, 2022. ; https://doi.org/10.1101/2022.03.23.22272167 doi: medRxiv preprint larger share of cases during the pandemic (9.6% of cases at the 4 institutions) than before the pandemic (4.3% of cases) and Maimonides had a smaller share of cases during the 153 pandemic (10.2% of cases) than before the pandemic (17.5% of cases) (p=0.03); there 154 were no significant differences between other institutions. Gender, age at diagnosis, 155 diagnosis, county of residence, race, and ethnicity did not differ pre-pandemic versus post-156 pandemic. 157 We noted more CD diagnoses than expected in June and July during the pandemic 158 compared with before the pandemic in the loess plots [ Figure 1 ]. 159 We noted more CD cases than forecast in the third quarter of 2020, which had 26 Table 2 compares 183 the demographic data for these 3 institutions: as before, we notice that Downstate had 184 more cases than usual during the pandemic than before the pandemic, and Maimonides 185 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 27, 2022. ; https://doi.org/10.1101/2022.03.23.22272167 doi: medRxiv preprint had fewer, but there were no other differences; these three institutions do not report 186 Hispanic ethnicity.

The pre-pandemic model for quarterly ulcerative colitis was ARIMA(0,0,0) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 27, 2022. ; https://doi.org/10.1101/2022.03.23.22272167 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 27, 2022. ; Figure 5 : Time series with prediction intervals (PI) forecast for 3 institutions: monthly ulcerative colitis (UC) and Crohn's disease (CD) cases.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 27, 2022. ; . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 27, 2022. ; P-value from chi-square test of association between each variable and pre-pandemic versus postpandemic with simulated p-value.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 27, 2022. ; https://doi.org/10.1101/2022.03.23.22272167 doi: medRxiv preprint

Incidence of New-Onset Type 1 Diabetes Among US Children During the COVID-19 Global Pandemic

COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years -United States

Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses

We would like to acknowledge the contributions of the following individuals, Dalia Arostegui MD, Chika Oragui MD, Agata Mann MD, Jon Dooley MD, and Dr. Melanie Greifer MD who assisted in data collection, and Steven Schwarz MD who assisted in building our data gathering collaboration.